The store will not work correctly when cookies are disabled.
6-Bromo-3-(3-chlorostyryl)-2-methylquinazolin-4(3H)-one
ID: ALA5280935
Max Phase: Preclinical
Molecular Formula: C17H12BrClN2O
Molecular Weight: 375.65
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccc(Br)cc2c(=O)n1/C=C/c1cccc(Cl)c1
Standard InChI: InChI=1S/C17H12BrClN2O/c1-11-20-16-6-5-13(18)10-15(16)17(22)21(11)8-7-12-3-2-4-14(19)9-12/h2-10H,1H3/b8-7+
Standard InChI Key: CDAZDGMTXNAGLK-BQYQJAHWSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-3.5700 -0.2040 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-2.8556 -0.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8556 -1.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1394 -1.8528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4295 -1.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7119 -1.8551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -1.4386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7138 -1.8511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -0.6178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7120 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4264 -0.6178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1409 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8584 -0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5700 -0.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5700 0.6176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8538 1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1409 0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8538 1.8551 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.7170 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7170 0.6194 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4295 -0.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1412 -0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
16 18 1 0
9 19 1 0
19 20 2 0
21 19 1 0
5 21 2 0
21 22 1 0
22 2 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.65 | Molecular Weight (Monoisotopic): 373.9822 | AlogP: 4.75 | #Rotatable Bonds: 2 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.68 | CX LogP: 4.48 | CX LogD: 4.48 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.65 | Np Likeness Score: -0.99 |
References
1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203] [10.1016/j.ejmech.2018.03.076] |